Company and Industry Summary Company: 罗新药业 (Luo Xin Pharmaceutical) Key Points - 罗新药业 is undergoing a transformation from a textile pharmaceutical company to an innovative pharmaceutical company, which has led to the divestiture of several subsidiaries over the past two years [1] - The company has not met its performance expectations, resulting in specific financial losses [1] - There has been a significant asset impairment loss related to the company's attempt to sell its subsidiary 乐康吃药 (Le Kang Pharmaceutical) [1] - In November 2024, the company is strategically optimizing its asset allocation by continuing to sell 乐康之钥 (Le Kang Zhi Yao), but has faced challenges in finding buyers, with the sale price decreasing after multiple attempts [1]